SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000921895-18-001200
Filing Date
2018-04-04
Accepted
2018-04-04 16:30:30
Documents
2

Document Format Files

Seq Description Document Type Size
1 sc13d07042012_04042018.htm SC 13D 169261
2 JOINT FILING AGREEMENT ex991to13d07042012_04042018.htm EX-99.1 8235
  Complete submission text file 0000921895-18-001200.txt   179270
Mailing Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202
Business Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202 (904) 516-5436
TAPIMMUNE INC. (Subject) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-58217 | Film No.: 18737589
SIC: 2834 Pharmaceutical Preparations

Mailing Address 641 LEXINGTON AVENUE 26TH FLOOR NEW YORK, NY 10022
Business Address 641 LEXINGTON AVENUE 26TH FLOOR NEW YORK, NY 10022 212.974.3070
Iroquois Capital Management, LLC (Filed by) CIK: 0001481867 (see all company filings)

IRS No.: 010786483 | State of Incorp.: DE
Type: SC 13D